semaglutide hypothalamus drives weight loss through cAMP-dependent mechanisms in GLP1R-expressing hindbrain neurons Semaglutide reduces hypothalamic glial cell

According to the Wegovy Summary of Product Characteristics (SmPC), semaglutide does not significantly affect the cytochrome P450 enzyme system, which metabolises many drugs, and ibuprofen does not interfere with GLP-1 receptor activity

There is a fiscal-rule scoring problem behind this

Nabil Boulos, specialist pharmacist in paediatric endocrinology and diabetes at Southampton Childrens Hospital, says the data show a welcome drop in the quantity of videos promoting weight-loss products

New molecular forms of cholecystokinin

When levels are too low, DNA can be copied incorrectly, leading to mutations that, over many years, may increase the risk of certain cancers, particularly colon cancer